Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 165 entries
View as:

Study of PembrolizumAb combiNeD With Cisplatin or carbOplatin and Etoposide in Treatment naïve Advanced meRkel Cell cArcinoma (MCC)

Phase: N/A Priority: Normal
NCT ID: NCT06086288 Org: User:
Start: 11/30/23 End: 12/31/27 Due: 12/31/28

Tertiary Prevention of Head and Neck Cancer With a Dietary Intervention

Phase: N/A Priority: Normal
NCT ID: NCT02869399 Org: User:
Start: 11/30/15 End: 02/28/23 Due: 02/28/24

Indocyanine Green-guided Lymphadenectomy in Laparoscopic Total Mesorectal Excision for Low Rectal Cancer After Neoadjuvant Chemoradiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05873621 Org: User:
Start: 01/01/23 End: 12/30/23 Due: 12/30/24

NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03832621 Org: User:
Start: 03/25/19 End: 09/30/21 Due: 09/30/22

Whole Body Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01829412 Org: User:
Start: 07/31/08 End: 07/31/12 Due: 07/31/13

Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02262221 Org: User:
Start: 06/30/14 End: 12/31/23 Due: 12/31/24

A Study of Niraparib in Combination With Abemaciclib for Late Line Treatment of Ovarian Cancer (NICHOL TRIAL)

Phase: N/A Priority: Normal
NCT ID: NCT06594679 Org: User:
Start: 09/26/24 End: 09/18/27 Due: 09/18/28

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

Phase: N/A Priority: Normal
NCT ID: NCT06805812 Org: User:
Start: 05/01/23 End: 12/31/40 Due: 12/31/41

Epithelioid Haemangioendothelioma Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT06680401 Org: User:
Start: 02/25/21 End: 02/28/26 Due: 02/28/27

The ImmunoXXL Study

Phase: N/A Priority: Normal
NCT ID: NCT05879328 Org: User:
Start: 12/23/22 End: 12/31/24 Due: 12/31/25

Activity of Sorafenib in Salivary Gland Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01703455 Org: User:
Start: 09/30/10 End: 01/31/13 Due: 01/31/14

Prospective Observational Study on Plerixafor After Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01700608 Org: User:
Start: 09/30/08 End: 04/30/12 Due: 04/30/13

Prospective Translational Study Investigating Possible Molecular prEdictors of Resistance to First-Line pazopanIb

Phase: N/A Priority: Normal
NCT ID: NCT04462445 Org: User:
Start: 06/25/15 End: 02/08/17 Due: 02/08/18

A Comparison Between TOF Watch® SX and Tetragraph®

Phase: N/A Priority: Normal
NCT ID: NCT04947306 Org: User:
Start: 08/24/20 End: 10/30/20 Due: 10/30/21

Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03081923 Org: User:
Start: 02/01/17 End: 12/06/19 Due: 12/06/20

The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)

Phase: N/A Priority: Normal
NCT ID: NCT06408441 Org: User:
Start: 12/01/23 End: 12/01/33 Due: 12/01/34

Implant-based Breast Reconstruction and Mastectomy With Fat Grafting After Breast Conserving Surgery and Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06119633 Org: User:
Start: 06/30/07 End: 12/31/23 Due: 12/31/24

Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen

Phase: N/A Priority: Normal
NCT ID: NCT03844685 Org: User:
Start: 07/05/12 End: 02/23/16 Due: 02/23/17

Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02960711 Org: User:
Start: 02/28/14 End: 07/31/19 Due: 07/31/20

I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05537922 Org: User:
Start: 10/01/22 End: 10/01/27 Due: 10/01/28

Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02268747 Org: User:
Start: 11/30/14 End: 11/30/16 Due: 11/30/17

Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05649943 Org: User:
Start: 03/01/23 End: 01/01/29 Due: 01/01/30

Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery

Phase: N/A Priority: Normal
NCT ID: NCT02535351 Org: User:
Start: 11/30/15 End: 09/28/18 Due: 09/28/19

Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study

Phase: N/A Priority: Normal
NCT ID: NCT05019989 Org: User:
Start: 06/01/08 End: 09/30/17 Due: 09/30/18

Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.

Phase: N/A Priority: Normal
NCT ID: NCT05284305 Org: User:
Start: 03/01/22 End: 05/15/23 Due: 05/15/24